Korean Stock
OTHR
D&D Pharmatech
★
Outside Director Change Disclosure (No Change)
 05/18/2026, 03:56 PM
OWNR
D&D Pharmatech
★
Submission of Report on Ownership of Specific Securities by Executives and Major Shareholders
 05/15/2026, 04:30 PM
PERI
D&D Pharmatech
★
D&D Pharmatech Q1 2026: Operating loss widens, but DD01 Ph2 success and pipeline progress
 05/15/2026, 02:48 PM
EXCH
D&D Pharmatech
★
Result of Issuance of 2nd Convertible Bonds (KRW 226.5 Billion)
 05/03/2026, 07:00 AM